The cannabis industry is growing worldwide and Mexico is no exception, but there are still legal issues when allowing businesses to produce and sell cannabis products. Canninus is the first company in Mexico to specialize in cannabis supplements for dogs. The products offered by Canninus are made from THC-free cannabis ingredients which can be bought online or in retail stores.
After Rodolfo Zuñiga lost his pet in 2017 to a chronic illness, he decided to create a new line of cannabis pet products. He aims to use cannabidiol (CBD), a cannabis derivative that has no psychoactive effects, to help treat sick dogs.
“I was living in Mexico when my dog passed away. I knew about the use of cannabis pet products that I could access in California, but I couldn’t get them in my country. That’s how I decided to combine my experience in the cannabis industry and my love for animals to make a line of dog products,” explained Rodolfo.
Hemp.im is a mobile application that is exclusively dedicated to hemp and cannabis news as well as the very latest news about the general hemp and cannabis industry.
Rodolfo had worked on a cannabis farm in California and knew about the uses of CBD for people and animals.
After researching its applications in the veterinary industry he developed Canninus, the first company in Mexico to specialize in cannabis pet products and supplements for dogs.
Currently, Canninus has four consumer products for dogs, plus a shampoo and a leash. All those products are made from THC-free cannabis ingredients and supplies from Colorado and California.
The company’s goal is to market these cannabis pet products in Mexico through independent distributors, retailers, and the company’s online store. Rodolfo, as well as many entrepreneurs in the cannabis industry, are trying to launch products while entering the market legally.
More than 50 industrial products based on cannabis oil (which contain CBD) have required the endorsement of the Federal Commission for Health Risk Assessment (Cofepris) for marketing, export, and import. Currently, only 38 have obtained endorsement from Cofepris.
Despite the progress, there are some pending issues to be resolved in order to help the industry. These include the lack of a legal framework that establishes the rules for the production, import, commercialization and use of cannabis for medicinal purposes in Mexico.
“The vote was supposed to happen in 2019 but an extension was requested and will be pushed a few more months,” explained Lorena Beltrán, General Director of CannabisSalud.
Beltrán is also the Co-Founder of Endonatura Labs and President of the New Mexican Association of the Regenerative Cannabis Industry.
For now, entrepreneurs in the sector recognize that there is a “gray market” that has grown due to the lack of regulation, and many have resorted to “protection” to be able to operate.
“Officially we could operate already, but there are no regulations yet. That is why we say that it is no longer a black market, but a grey area. This encourages an infinite number of products to be sold online. But without the endorsement of Cofepris, which is a risk for the consumer,” added Lorena.
The cannabis industry is growing worldwide and Mexico is no exception. According to the stud, ” Getting Started: CBD and Cannabis in Latin America Report 2019,” the domestic market amounts to $18 million and by 2023 it will reach $258 million.
Currently, Mexico is following the lead of several other countries that already have legalized cannabis.
__
(Featured image by Pharma Hemp Complex via Unsplash)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Hemp.im, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in Entrepreneur, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
Berlin is launching a pilot project in the Friedrichshain-Kreuzberg and Neukölln districts to study the…
The Czech Constitutional Court overturned a previous ruling accusing Robert Veverka, former editor of Legalizace,…
U.N. High Commissioner for Human Rights Volker Türk has declared the war on drugs a…
Pennsylvania lawmakers have proposed a plan to legalize recreational cannabis by 2025. Projections estimate up…
The DEA just held its first procedural hearing on cannabis reclassification, although the focus was…
The Superior Court of Justice in Brazil has legalized the cultivation, processing, and sale of…